Plasma viral load is helpful in monitoring systemic HIV infection but the relationship between plasma viral load and CNS functioning remains unclear. Equivocal results have been reported on the relationship between plasma viral load and cognitive functioning. The present study tested cognitive functions with a standardized neuropsychological battery consisting of 28 test scores. Participants (N = 140) were grouped into undetectable (<400 copies), low (401-10,000 copies), or moderate (10,001-100,000 copies) viral load groups. Statistical analyses (MANOVA and MANCOVA) revealed no differences in neuropsychological test performance between the viral load groups. Fairly healthy patients with moderate plasma viral loads do not appear to show increased neuropsychological dysfunction. CSF viral load may be more helpful in evaluating cognitive correlates of HIV encephalitis.
from mild cognitive deficits at the asymptomatic stage of infection to HIV dementia (Reger, Welsh, Razani, Martin, & Boone, 2002) .
The mechanisms of cognitive impairment in HIV infection remain unclear. Although dementia appears to be related to neuronal dysfunction and death, HIV does not directly infect neurons (Kaul, Garden, & Lipton, 2001 ). Instead, a number of theories have hypothesized that infection begins a cascade of events that indirectly results in neuronal injury and associated cognitive deficits (Masliah, Ge, & Mucke, 1996; Tyler and McArthur, 2002) .
The relationship between viral load and the mechanisms of cognitive decline requires further study. Cerebrospinal fluid (CSF) HIV ribonucleic acid (RNA) is elevated in subjects with cognitive impairments (Ellis et al., 1997; McArthur et al., 1997) and CSF HIV RNA predicts future neuropsychological impairment (Ellis et al., 2002) . Clinically, however, a relationship between plasma HIV RNA levels and cognitive impairment would be more useful. Higher plasma HIV RNA levels may be associated with higher levels of circulating HIV-infected monocytes which may affect CNS functioning (Gartner, 2000) . However, research on the relationship between plasma viral load and cognitive functioning remains equivocal. Ellis et al. (1997) failed to find a relationship between overall impairment ratings and plasma HIV RNA. However, in a small neuropsychological battery, Stankoff et al. (1999) found a significant relationship between motor functioning and plasma viral load. In addition, contradictory results regarding the relationship between plasma HIV RNA levels and incident neuropsychological impairment have been reported (Childs et al., 1999; Ellis et al., 2002) . The goal of this study was to clarify the relationship between cognitive functioning and plasma HIV RNA levels with a comprehensive neuropsychological battery in a large HIV+ cohort.
Method

Participants
The sample for this study consisted of 140 individuals with HIV/AIDS enrolled in a longitudinal vocational rehabilitation/workforce entry demonstration project for people with HIV/AIDS. For the purposes of this analysis, subjects were excluded if they had major psychiatric disorders, substance use disorders, a hospitalization due to head injury, or if they were not fluent in English. No subject had a neurological disorder. Participants' mean age was 39.2 (S.D. = 6.2) with an average of 13.4 years of education (S.D. = 2.0). Most subjects were male (n = 125). Seventy-one were white (51%), 36 (26%) were African American, 24 (17%) were Hispanic, 4 (3%) were Asian or Pacific Islander, and 5 (4%) were of other ethnicities. Sixteen subjects were asymptomatic, 30 were symptomatic, and 91 had AIDS. The median CD4 count was 350 l −1 . All subjects were receiving antiretroviral treatment (Table 1) .
Procedures
Neuropsychological testing
All participants received neuropsychological testing from trained masters-level psychology students following standardized procedures under the supervision of a board-certified neuropsychologist. The neuropsychological test battery was assembled following a review of the literature on neuropsychological functioning among people with HIV/AIDS, and was designed to achieve consistency with the recommendations of the NIMH Working Group on Neuropsychological Assessment Approaches in HIV Infection and AIDS (Butters, Grant, Haxby, & Judd, 1990) . Specific tests in the neuropsychological battery are listed in Table 2 .
Statistical analyses
Subjects were classified into discrete groups based on plasma HIV RNA levels determined with reverse transcriptase polymerase chain reaction (PCR) techniques prior to cognitive testing. Subjects were classified as undetectable (<400 copies/ml; n = 72), low (401-10,000 copies/ml; n = 42), or moderate (10,001-100,000 copies/ml; n = 26). These groups were analyzed for differences in age, education, gender, percent nonwhite, depression, and CD4 lymphocyte counts. MANOVAs were then conducted with plasma HIV RNA group entered as the independent factor and the neuropsychological tests within each cognitive domain entered as the dependent variables. Seven cognitive domains were tested, resulting in seven MANOVAs. The analyses were repeated with age, education, and CD4 lymphocyte counts entered as covariates.
Results
Demographic, medical, and depression information
Undetectable, low, and moderate viral load groups did not differ in terms of age, education, percent male, percent non-white, or depression. There was a non-significant trend for subjects with higher viral loads to have lower CD4 lymphocyte counts. These results are displayed in Table 1 .
Plasma HIV RNA levels and neuropsychological functioning
Plasma HIV RNA groups did not differ in their performance on tests of attention F(10, 242) = 1.06, P = .40, language F(6, 242) = .78, P = .59, visual-perceptual skills F(6, 248) = Table 2 . The findings did not change when the analyses were repeated with age, education, and CD4 count entered as covariates.
Discussion
The results of this study suggest that plasma HIV RNA levels may not predict the degree of neuropsychological disturbance in HIV infection among patients receiving antiretroviral treatment. Analysis of neuropsychological test performance among a cohort of people with HIV infection revealed no differences between groups with undetectable, low, or moderate plasma HIV RNA levels. These results are consistent with the findings of Ellis et al. (1997) who reported no relationship between HIV RNA levels in plasma and neurocognitive impairment. Our results contrast in some ways with the findings of Stankoff et al. (1999) who found a significant correlation between psychomotor speed and HIV RNA levels. However, they reported no other significant findings with their other cognitive tests and concluded that plasma HIV RNA is a poor predictor of HIV-1 associated cognitive disorders overall. One 10-year study has reported that high baseline plasma HIV RNA levels resulted in a relative hazard of dementia 8.5 times higher than those with low baseline HIV RNA levels (Childs et al., 1999) . Differences in methods, such as their inclusion of subjects with much higher plasma HIV RNA levels, and their longitudinal, prospective design, make a direct comparison with our results difficult.
Although some theories on the development of neurological disease in HIV infection continue to stress the importance of peripheral events, especially in late-stage HIV (Gartner, 2000) , plasma HIV RNA may be too far removed in the causal cascade from the events that eventually cause neuronal injury to be of any predictive value. CSF viral load may be more helpful in evaluating the cognitive correlates of HIV encephalitis. CSF HIV RNA levels do not simply mirror plasma levels (Bossi et al., 1998) . Plasma HIV RNA levels are generally significantly higher than CSF levels, but when subjects with HIV dementia are examined, the reverse pattern is often observed (Di Stefano, Monno, Fiore, & Angarano, 1997) . The source of CSF virus remains unknown, but some evidence suggests that the source transitions from infected cells in blood early in infection to sources within the CSF itself later in the course of the disease (Ellis et al., 2000) . Early evidence indicates CSF HIV RNA predicts cognitive functioning in at least a subset of HIV patients (Cinque et al., 1998; Ellis et al., 1997 Ellis et al., , 2002 McArthur et al., 1997) .
Several limitations of this study suggest that additional research in this area may be helpful. The study suffers from selection bias. Subjects were pursuing vocational rehabilitation and had relatively low to moderate plasma HIV RNA levels overall, and all were receiving antiretroviral treatment. Viral load's restricted range, in addition to the fact that CD4 lymphocyte counts did not differ significantly between viral load groups, suggests that these results may apply only to fairly healthy patients with low to moderate plasma HIV RNA levels. These results do not rule out the possibility of increased neuropsychological deficits among patients with high viral loads. Additional research on the relationship between cognitive functioning and plasma HIV RNA with a broader range of viral levels may be helpful. In addition, research examining subjects in and out of treatment, and the cognitive effects of long exposures to high viral levels may be useful.
